QGEN (Qiagen NV) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QGEN Qiagen NV QGEN
75 GF Score
Price $43.33
GF Value $49.42
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Qiagen NV Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Qiagen NV  (NYSE:QGEN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Qiagen NV Cyclically Adjusted PS Ratio Related Terms


Qiagen NV Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Qiagen NV's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qiagen NV Cyclically Adjusted PS Ratio Chart

Qiagen NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 6.15 5.21 4.94 4.64

Qiagen NV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 4.57 4.60 3.84 3.71

QGEN vs TWST, RDNT, SHC: Cyclically Adjusted PS Ratio Comparison

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted PS Ratio falls into.


QGEN
75GF Score
Qiagen NV QGEN
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qiagen NV Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Qiagen NV's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Qiagen NV's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.574/137.7000*137.7000
=2.574

Current CPI (Jun. 2026) = 137.7000.

Qiagen NV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.647 100.570 2.255
201612 1.773 100.710 2.424
201703 1.462 101.440 1.985
201706 1.674 101.370 2.274
201709 1.746 102.030 2.356
201712 1.955 101.970 2.640
201803 1.649 102.470 2.216
201806 1.801 103.100 2.405
201809 1.794 103.950 2.376
201812 1.937 103.970 2.565
201903 1.666 105.370 2.177
201906 1.830 105.840 2.381
201909 1.886 106.700 2.434
201912 1.995 106.800 2.572
202003 1.789 106.850 2.306
202006 2.114 107.510 2.708
202009 2.290 107.880 2.923
202012 2.715 107.850 3.466
202103 2.725 108.870 3.447
202106 2.730 109.670 3.428
202109 2.571 110.790 3.195
202112 2.805 114.010 3.388
202203 3.047 119.460 3.512
202206 2.502 119.050 2.894
202209 2.424 126.890 2.631
202212 2.413 124.940 2.659
202303 2.349 124.720 2.593
202306 2.396 125.830 2.622
202309 2.303 127.160 2.494
202312 2.463 126.450 2.682
202403 2.192 128.580 2.347
202406 2.421 129.910 2.566
202409 2.425 131.610 2.537
202412 2.516 131.630 2.632
202503 2.311 133.330 2.387
202506 2.574 133.960 2.646
202509 2.566 135.920 2.600
202512 2.601 135.470 2.644
202603 2.356 136.840 2.371
202606 2.574 137.700 2.574

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Qiagen NV (QGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued. The current stock price of $43.33 is trading 12.3% below its estimated GF Value™ of $49.42. GuruFocus considers Qiagen NV to be Modestly Undervalued.

Key valuation signals for QGEN:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $49.42 vs. price of $43.33 (12.3% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the QGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qiagen NV Business Description

Address Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
75GF Score

Get the complete analysis for QGEN

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.33
Price
$49.42
GF Value